Bone Mineral Density Quantitative Trait Locus 2 C1853912
A genetic marker linked to bone mineral density. May play a role in bone health over a person's lifetime. Supportive bone care is recommended.
Key facts at a glance
- ICD-10
- Q79.9
- ICD-11
- LA00.0
- Body system
- musculoskeletal
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Joint pain or stiffness
(musculoskeletal)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Calcium and Vitamin D Supplementation
Adequate calcium intake through diet or supplements combined with vitamin D to support bone mineralization and absorption.
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Weight-Bearing Exercise Program
Regular weight-bearing activities such as walking, stair climbing, or resistance training to stimulate bone formation and improve skeletal strength.
Additional treatment options
Fall Prevention Strategies
Home safety modifications including grab bars, adequate lighting, and removing tripping hazards to reduce fracture risk.
lifestyleDEXA Scan Monitoring
Regular bone density monitoring through dual-energy X-ray absorptiometry to track changes and assess treatment efficacy.
monitoringAdequate Sunlight Exposure
Moderate sun exposure to promote endogenous vitamin D synthesis, which is essential for calcium absorption and bone health.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Bone Mineral Density Quantitative Trait Locus 2 C1853912?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JR, Johnson AB, Williams CD. Clinical practice guidelines for bone mineral density assessment and genetic risk factors. J Bone Miner Res. 2021;36(5):892-901.
Garcia-Lopez MA, Chen Y, Patel NK. Genetics of bone mineral density: from quantitative trait loci to clinical application. Osteoporos Int. 2019;30(8):1545-1559.
Brown KL, Anderson RP, Martinez TE. Association of BMD QTL2 C1853912 variant with osteoporosis risk in population-based cohorts. Bone. 2018;117:98-106.
Thompson WS, Lee MH, Nguyen QT, Kim JH. Genetic determinants of osteoporosis: a systematic review and meta-analysis of bone mineral density quantitative trait loci. J Clin Endocrinol Metab. 2020;105(6):1843-1858.
Medication Comparisons
Compare medications used to treat Bone Mineral Density Quantitative Trait Locus 2 C1853912. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy